Lyme Disease Treatment Denied by Insurance? Your Options

Lyme disease is the most common vector-borne illness in the United States, with the CDC estimating approximately 476,000 Americans diagnosed and treated each year. Despite its prevalence, patients — particularly those with persistent, late-stage, or atypical presentations — face significant barriers to insurance coverage. If your claim for Lyme disease treatment was denied, whether for antibiotics, specialist visits, diagnostic testing, or long-term care, you have the right to appeal and a meaningful chance of success.

Why Insurers Deny Lyme Disease Treatment

Lyme disease coverage denials arise from a specific clinical and regulatory landscape that is important to understand before you appeal.

Long-term antibiotic therapy denials are the most common and most contested. The Infectious Diseases Society of America (IDSA) 2020 Clinical Practice Guidelines do not recommend prolonged antibiotic therapy for Post-Treatment Lyme Disease Syndrome (PTLDS, ICD-10: A69.20). Insurers typically align their clinical coverage policies with IDSA guidelines, meaning treatment recommended by Lyme-literate physicians outside the IDSA framework is often denied as not medically necessary. However, several states — including Connecticut, Rhode Island, Massachusetts, New York, and California — have passed laws restricting insurers from penalizing physicians for recommending long-term Lyme treatment or requiring coverage for clinically appropriate persistent Lyme care. Know whether your state has such a statute.

Diagnostic testing denials occur because Lyme disease is difficult to diagnose, and some patients require testing beyond the two-tier CDC standard (ELISA followed by Western blot, ICD-10 diagnostic code Z13.88 for Lyme disease screening). Specialized labs and PCR-based or culture-based tests are sometimes denied as experimental or not medically necessary. If standard two-tier testing has been inconclusive and your treating physician has documented clinical reasons for additional testing, that documentation is the foundation of the appeal.

Specialist visit denials arise when insurers refuse to cover consultations with Lyme specialists who are out-of-network or whose practice model the insurer does not recognize. Document the medical necessity of specialist evaluation when standard care providers have been unable to manage your symptoms.

Co-infection treatment denials occur because Lyme disease is frequently accompanied by co-infections such as babesiosis (ICD-10: B60.00), anaplasmosis (ICD-10: A77.49), or Bartonella. Coverage for treatment of these co-infections may be denied separately from the Lyme denial.

How to Appeal a Lyme Disease Treatment Denial

Step 1: Identify the Specific Denial Basis

Read your EOB)" class="auto-link">Explanation of Benefits (EOB) and denial letter carefully. Is the denial based on: medical necessity (long-term antibiotics not supported by guidelines); experimental/investigational classification of a diagnostic test; out-of-network provider; or an exclusion? The specific basis determines the appeal approach. For ERISA plans, you are entitled to the full claim file under 29 C.F.R. § 2560.503-1 — request it before drafting your appeal.

Step 2: Know Your State Law Protections

Several states have enacted Lyme disease insurance protections. Connecticut General Statutes § 38a-492s requires insurers to cover long-term antibiotic therapy for Lyme disease when a licensed physician determines it is clinically necessary. Rhode Island General Laws § 27-20-56 contains similar provisions. If you are in a state with such protections, cite the statute explicitly in your appeal. For states without specific Lyme statutes, ERISA and ACA medical necessity appeal rights still apply.

Step 3: Obtain a Detailed Letter from Your Treating Physician

Ask your Lyme-literate physician to write a letter that: documents your diagnosis using ICD-10 codes (A69.20 for disseminated Lyme borreliosis, A69.22 for Lyme disease with neurological involvement, A69.21 for Lyme carditis); explains the clinical rationale for the specific treatment plan; describes your treatment history and why shorter antibiotic courses were inadequate for your specific presentation; cites peer-reviewed literature supporting the approach; and documents your functional impairment — cognitive difficulties, inability to work, physical limitations. The specificity of this letter is the primary determinant of your appeal outcome.

Step 4: Submit Your Written Internal Appeal

File a formal written appeal addressing the insurer's specific denial grounds. If the insurer cited IDSA guidelines, your physician's letter should engage with those guidelines and explain why your clinical presentation and history warrant a different approach. Attach functional assessments, symptom diaries, prior treatment records, and all positive diagnostic results. For state-regulated plans in Lyme-protection states, cite the applicable statute.

Step 5: Request External Independent Review: Complete Guide" class="auto-link">External Review

If your internal appeal is denied, request independent external review. Select a reviewer with infectious disease or internal medicine expertise. External reviewers are required to evaluate whether the treatment is clinically appropriate given the full medical record — not simply whether it aligns with a particular guideline set. External review is free to you and produces a binding decision.

Step 6: File a State Insurance Department Complaint

If you believe your insurer is applying overly restrictive criteria or failing to apply state Lyme disease protections, file a complaint with your state insurance commissioner. State regulators have authority to investigate insurer compliance with state-specific statutes and can require corrective action.

What to Include in Your Appeal

• The insurer's denial letter and EOB identifying the specific denial basis and clinical criterion cited
• Physician letter of medical necessity using ICD-10 codes (A69.20, A69.22, A69.21 as applicable), documenting your diagnosis, treatment history, functional impact, and the clinical rationale for the specific treatment being appealed
• Complete medical records: positive Lyme test results, prior treatment records, office visit notes documenting symptom burden, specialist consultation letters, and co-infection test results where relevant
• State statutory citation if your state has enacted Lyme disease insurance coverage protections (Connecticut, Rhode Island, and others)
• Peer-reviewed literature supporting the treatment approach your physician recommends, if available — particularly evidence from the International Lyme and Associated Diseases Society (ILADS) or other clinical bodies

Fight Back With ClaimBack

Lyme disease patients frequently fight two battles simultaneously — with their illness and with their insurer. The insurance battle is winnable, particularly when the appeal is specific, clinically documented, and engages directly with the insurer's stated denial reason rather than making a general appeal for coverage. ClaimBack generates a professional appeal letter in 3 minutes.

Start your free claim analysis →

Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal